Allogene Therapeutics Inc (ALLO) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Allogene Therapeutics Inc   (NASDAQ: ALLO)

Allogene Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALLO Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 71.11 % 65.43 % 47.43 %
Gross Margin (Q2 TTM) 0 % 79.56 % 66.39 % 46.67 %
Gross Profit Margin 5 Yr. Avg. - 70.97 % 65.56 % 47.82 %
EBITDA Margin (Q2 MRQ) 49.53 % 20.59 % 19.59 % 21.4 %
EBITDA Margin (Q2 TTM) -1788.13 % 27.11 % 20.86 % 19.31 %
EBITDA Margin 5 Yr. Avg. - 22.75 % 31.56 % 22.46 %
Operating Margin (Q2 MRQ) -878.65 % 11.28 % 16.57 % 16.73 %
Operating Margin (Q2 TTM) -2636.21 % 16.53 % 17.92 % 16.52 %
Operating Margin 5 Yr. Avg. - 6.03 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 7.4 % 10.93 % 14.14 %
Pre-Tax Profit Margin (Q2 TTM) -1795.57 % 15.08 % 12.86 % 13.13 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.88 % 10.37 % 12.42 %
Net Margin (Q2 MRQ) -799.19 % 2.64 % 8.14 % 11.6 %
Net Margin (Q2 TTM) -2419.5 % 11.11 % 9.99 % 10.8 %
Net Margin 5 Yr. Avg. - 6.58 % 6.08 % 9.9 %



Business Segment Profit Margin
 
Reportable
  Explore Reportable Segment  -